Cathay Biotech Sees Three Block Trades Worth RMB 70.05 Million; Institutions Net Sell RMB 43.69 Million
Cathay Biotech executed three block trades on September 11, 2026, totaling 1.7573 million shares for RMB 70.0459 million, all at RMB 39.86 per share. Institutional seats appeared on the buy or sell side of all three trades, with combined turnover of RMB 70.0459 million and net selling of RMB 43.6865 million. The stock closed at RMB 39.86, up 0.66 percent, with a turnover rate of 2.06 percent and RMB 477 million in trading value.
On September 11, 2026, Cathay Biotech completed three block trades totaling 1.7573 million shares for RMB 70.0459 million, all at a price of RMB 39.86 per share. Institutional seats appeared among the buying or selling brokerage branches in all three trades, with combined turnover of RMB 70.0459 million and net selling of RMB 43.6865 million.
In the first trade, 1.0062 million shares changed hands for RMB 40.1071 million at RMB 39.86 per share, a premium or discount of 0.00% to the day's closing price. The buyer was UBS Securities Co. , Ltd.' s Shanghai Huayuan Shiqiao Road securities branch, and the seller was an institutional seat. In the second trade, 661,300 shares were traded for RMB 26.3594 million at RMB 39.86 per share, also a 0.00% premium or discount to the close, with both buyer and seller being institutional seats. In the third trade, 89,800 shares were traded for RMB 3.5794 million at RMB 39.86 per share, a 0.00% premium or discount to the close, with the buyer being the headquarters of Guotai Haitong Securities Co. and the seller an institutional seat.
On September 11, 2026, Cathay Biotech closed at RMB 39.86, up 0.66%, with a daily turnover rate of 2.06% and trading value of RMB 477 million. Net outflow of main funds for the full day was RMB 32.9946 million. Over the past five trading days, the stock fell 3.77% cumulatively, with a total net outflow of RMB 38.6364 million. The stock's latest margin financing balance stood at RMB 843 million, an increase of RMB 32.6424 million, or 4.03%, over the past five days. Shanghai Cathay Biotech Inc. was established on November 24, 2000, with registered capital of RMB 721.289794 million.